Stability, Intracellular Delivery, and Release of siRNA from Chitosan Nanoparticles Using Different Cross-Linkers

PLoS One. 2015 Jun 11;10(6):e0128963. doi: 10.1371/journal.pone.0128963. eCollection 2015.

Abstract

Chitosan (CS) nanoparticles have been extensively studied for siRNA delivery; however, their stability and efficacy are highly dependent on the types of cross-linker used. To address this issue, three common cross-linkers; tripolyphosphate (TPP), dextran sulphate (DS) and poly-D-glutamic acid (PGA) were used to prepare siRNA loaded CS-TPP/DS/PGA nanoparticles by ionic gelation method. The resulting nanoparticles were compared with regard to their physicochemical properties including particle size, zeta potential, morphology, binding and encapsulation efficiencies. Among all the formulations prepared with different cross linkers, CS-TPP-siRNA had the smallest particle size (ranged from 127 ± 9.7 to 455 ± 12.9 nm) with zeta potential ranged from +25.1 ± 1.5 to +39.4 ± 0.5 mV, and high entrapment (>95%) and binding efficiencies. Similarly, CS-TPP nanoparticles showed better siRNA protection during storage at 4˚C and as determined by serum protection assay. TEM micrographs revealed the assorted morphology of CS-TPP-siRNA nanoparticles in contrast to irregular morphology displayed by CS-DS-siRNA and CS-PGA-siRNA nanoparticles. All siRNA loaded CS-TPP/DS/PGA nanoparticles showed initial burst release followed by sustained release of siRNA. Moreover, all the formulations showed low and concentration-dependent cytotoxicity with human colorectal cancer cells (DLD-1), in vitro. The cellular uptake studies with CS-TPP-siRNA nanoparticles showed successful delivery of siRNA within cytoplasm of DLD-1 cells. The results demonstrate that ionically cross-linked CS-TPP nanoparticles are biocompatible non-viral gene delivery system and generate a solid ground for further optimization studies, for example with regard to steric stabilization and targeting.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Chitosan / chemistry*
  • Dextran Sulfate / chemistry
  • Drug Carriers / chemistry*
  • Drug Carriers / toxicity
  • Gels / chemistry
  • Humans
  • Nanoparticles / chemistry*
  • Nanoparticles / toxicity
  • Particle Size
  • Polyglutamic Acid / chemistry
  • Polyphosphates / chemistry
  • RNA, Small Interfering / chemistry
  • RNA, Small Interfering / metabolism*

Substances

  • Drug Carriers
  • Gels
  • Polyphosphates
  • RNA, Small Interfering
  • chitosan sulfate
  • Polyglutamic Acid
  • Chitosan
  • Dextran Sulfate
  • triphosphoric acid

Grants and funding

This work was supported by the Ministry of Higher Education Exploratory Research Grant Scheme ERGS/1/2011/SKK/UKM/02/11 to HK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.